loading

Protagonist Therapeutics Inc Azioni (PTGX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
80.42%
5.546
28.32 4.675 4.167 254.95
Operating Expenses
0.09%
47.59
47.63 46.13 42.96 48.64
Benefits Costs and Expenses
0.42%
40.15
39.98 38.30 35.46 44.29
Costs And Expenses
0.42%
40.15
39.98 38.30 35.46 44.29
Operating Income/Loss
117.72%
-42.04
-19.31 -41.45 -38.79 206.31
Income/Loss From Continuing Operations Before Tax
196.86%
-34.60
-11.65 -33.63 -31.29 210.67
Income Tax Expense/Benefit
0.172
- -0.42 -0.676 3.326
Income/Loss From Continuing Operations After Tax
198.34%
-34.77
-11.65 -33.21 -30.62 207.34
Net Income/Loss
198.34%
-34.77
-11.65 -33.21 -30.62 207.34
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.87%
63.51
62.96 61.77 61.31 60.86
Diluted Average Shares
0.87%
63.51
62.96 61.77 61.31 63.60
Basic Earnings Per Share
189.47%
-0.55
-0.19 -0.54 -0.50 3.41
Diluted Earnings Per Share
189.47%
-0.55
-0.19 -0.54 -0.50 3.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.00
price up icon 0.22%
$85.46
price up icon 0.64%
$25.35
price down icon 3.58%
$111.40
price down icon 1.02%
$127.21
price down icon 0.05%
biotechnology ONC
$312.51
price down icon 2.13%
Capitalizzazione:     |  Volume (24 ore):